Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,470Revenue $M85.6Net Margin (%)-18.6Z-Score13.0
Enterprise Value $M3,423EPS $-1.9Operating Margin %-13.5F-Score7
P/E(ttm))0Cash Flow Per Share $-2.0Pre-tax Margin (%)-18.6Higher ROA y-yY
Price/Book22.310-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsY
Price/Sales19.85-y EBITDA Growth Rate %-62.0Current Ratio1.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-14.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-36.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M36.1ROI % (ttm)-53.4Gross Margin Increase y-yY

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCRXJoel Greenblatt 2014-09-30 Reduce$83.31 - $108.26
($97.65)
$ 96.25-1%Reduce -26.78%6,946
PCRXMariko Gordon 2014-09-30 Reduce-1.21%$83.31 - $108.26
($97.65)
$ 96.25-1%Reduce -28.09%814,470
PCRXRon Baron 2014-09-30 Reduce-0.03%$83.31 - $108.26
($97.65)
$ 96.25-1%Reduce -59.75%62,139
PCRXRon Baron 2014-06-30 Add0.05%$63.61 - $91.01
($75.89)
$ 96.2527%Add 802.88%154,393
PCRXJoel Greenblatt 2014-06-30 Buy 0.01%$63.61 - $91.01
($75.89)
$ 96.2527%New holding, 9486 sh.9,486
PCRXMariko Gordon 2014-06-30 Reduce-0.66%$63.61 - $91.01
($75.89)
$ 96.2527%Reduce -17.39%1,132,552
PCRXMariko Gordon 2014-03-31 Add0.19%$55.83 - $80.43
($67.63)
$ 96.2542%Add 5.13%1,371,042
PCRXRon Baron 2014-03-31 Add$55.83 - $80.43
($67.63)
$ 96.2542%Add 163.28%17,100
PCRXMariko Gordon 2013-12-31 Add2.08%$47.74 - $56.97
($52.53)
$ 96.2583%Add 203.52%1,304,190
PCRXRon Baron 2013-12-31 Buy $47.74 - $56.97
($52.53)
$ 96.2583%New holding, 6495 sh.6,495
PCRXMariko Gordon 2013-09-30 Add0.93%$30.01 - $47.47
($36.37)
$ 96.25165%Add 3812.66%429,688
PCRXMariko Gordon 2013-06-30 Buy 0.02%$25.84 - $30.26
($28.93)
$ 96.25233%New holding, 10982 sh.10,982
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PCRX Joel Greenblatt 2014-09-306,9460.020.01-26.78%
PCRX Mariko Gordon 2014-09-30814,4702.263.5-28.09%
PCRX Ron Baron 2014-09-3062,1390.170.03-59.75%
Premium Most recent portfolio changes are included for Premium Members only!


PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Markvicka TauniaSVP, Chief Commercial Officer 2014-11-07Buy230$86.629.54view
Scibetta James SSVP, CFO 2014-11-07Sell15,000$87.188.83view
Kronenfeld Mark A.Director 2014-11-03Buy850$90.484.86view
STACK DAVID MPresident, CEO and Chairman 2014-10-15Sell15,000$99.49-4.63view
HASTINGS PAUL JDirector 2014-10-10Sell2,500$94.870.01view
LONGENECKER JOHN P PHDDirector 2014-09-29Sell1,000$96.4-1.58view
Wicki AndreasDirector 2014-08-29Sell21,494$108.11-12.24view
Wicki AndreasDirector 2014-08-27Sell55,813$108.08-12.21view
Wicki AndreasDirector 2014-08-11Sell150,000$101.25-6.29view
Scibetta James SSVP, CFO 2014-08-08Sell15,000$99.63-4.77view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

News about PCRX:

Articles On GuruFocus.com
Mariko Gordon's First Quarter Top Five May 15 2014 
Baron Funds Comments on Pacira Pharmaceuticals Mar 05 2014 
comment on PCRX Mar 15 2013 
Weekly CFO Buys Highlight: PCRX, UGI, MIG, GLT, IOSP Feb 27 2011 
Weekly CFO Buys Highlight: REFR, UGI, PCRX, NOIZ Feb 21 2011 
Pacira Pharmaceuticals Inc. (PCRX) CFO James S Scibetta buys 5,000 Shares Feb 16 2011 
Pacira Pharmaceuticals Inc. (PCRX) CEO David M Stack buys 5,000 Shares Feb 11 2011 

More From Other Websites
Nasdaq stocks posting largest percentage decreases Nov 25 2014
Pacira Pharmaceuticals, Inc. to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 25 2014
Pacira Pharmaceuticals, Inc. to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 25 2014
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira... Nov 24 2014
EQUITY ALERT: Rosen Law Firm Reminds Pacira Pharmaceuticals, Inc. Investors of Important December 2,... Nov 21 2014
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Nov 19 2014
Pacira Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor... Nov 18 2014
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira... Nov 17 2014
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Pacira Pharmaceuticals, Inc. Of... Nov 17 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Pacira... Nov 17 2014
Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2014 Global London Healthcare Conference Nov 11 2014
Pacira Pharmaceuticals Inc. Announces New Data on the Use of EXPAREL to Treat Postsurgical Pain... Nov 06 2014
Pacira Pharmaceuticals Inc. Announces New Data on the Use of EXPAREL to Treat Postsurgical Pain... Nov 06 2014
PACIRA PHARMACEUTICALS, INC. Financials Nov 06 2014
10-Q for Pacira Pharmaceuticals, Inc. Nov 01 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Pacira... Oct 31 2014
Pacira Down on Wider than Expected Q3 Loss, Sales Miss Oct 31 2014
Pacira Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today Oct 30 2014
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 30 2014
Q3 2014 Pacira Pharmaceuticals Inc Earnings Release - Before Market Open Oct 30 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK